AGEN News Alert Agenus Inc (AGEN) 5.03 02/14/2015 19:28:51

New Post Public Reply Private Reply Replies (0) Message Board

Feb 14, 2015 at 8:28 PM

Agenus Inc (AGEN) 5.03 $AGEN

Antigenics Shares Up 55.5% Since SmarTrend's Buy Recommendation (AGEN)
Comtex SmarTrend(R) - Tue Feb 10, 4:48PM CST
SmarTrend identified an Uptrend for Antigenics (NASDAQ:AGEN) on December 8th, 2014 at $3.30. In approximately 2 months, Antigenics has returned 55.45% as of today's recent price of $5.13.
AGEN: 5.03 (-0.01)

Agenus to Present at the 17th Annual BIO CEO & Investor Conference
Business Wire - Tue Feb 03, 10:30AM CST
Agenus Inc. (NASDAQ: AGEN), an immunology company developing a series of immune-oncology checkpoint modulators (CPMs), heat shock protein peptide-based vaccines, and immune adjuvants, today announced that the Company will present at the 17th Annual BIO CEO & Investor Conference on Monday, February 9th at 4:30 p.m. Eastern Time. The conference will take place at the Waldorf Astoria Hotel in New York City.
AGEN: 5.03 (-0.01)

Recent Developments at Pharma Companies: Special Research on Aerie Pharmaceuticals, AEterna Zentaris, Affimed, Agenus, and Agile Therapeutics
PR Newswire - Tue Feb 03, 7:30AM CST
Moments ago, Analysts Review released new research updates concerning several important developing situations including Aerie Pharmaceuticals (NASDAQ: AERI), AEterna Zentaris (NASDAQ: AEZS), Affimed (NASDAQ: AFMD), Agenus (NASDAQ: AGEN), and Agile Therapeutics (NASDAQ: AGRX). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
AGEN: 5.03 (-0.01), AGRX: 8.57 (-0.41), AFMD: 5.70 (-0.25), AEZS: 0.53 (unch), AERI: 27.91 (+0.14)

Biotech Stocks Technical Report - Halozyme Therapeutics, Agenus, Biogen Idec, ACADIA Pharma, and Peregrine Pharma
PR Newswire - Wed Jan 28, 7:40AM CST
Investor-Edge has initiated coverage on the following equities: Halozyme Therapeutics Inc. (NASDAQ: HALO), Agenus Inc. (NASDAQ: AGEN), Biogen Idec Inc. (NASDAQ: BIIB), ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), and Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM). Free research report on Halozyme Therapeutics can be accessed at http://get.Investor-Edge.com/pdf/?c=Halozyme%...amp;s=HALO. On Tuesday, January 27, 2015, the NASDAQ Composite ended at 4,681.50, down 1.89%, the Dow Jones Industrial Average declined 1.65%, to finish the day at 17,387.21, and the S&P 500 closed at 2,029.55, down 1.34%. The losses were broad based as nine out of ten sectors ended the session in negative. The S&P 500 Health Care Sector Index ended the day at 818.80, down 0.75%, while the index has advanced 8.40% in the previous three months. Register for your complimentary reports at the links given below.
AGEN: 5.03 (-0.01), BIIB: 391.66 (-0.45), ACAD: 34.21 (+0.37), HALO: 14.73 (+0.23), PPHM: 1.28 (+0.03)

57.3% Return Seen to Date on SmarTrend Antigenics Call (AGEN)
Comtex SmarTrend(R) - Mon Jan 26, 10:56AM CST
SmarTrend identified an Uptrend for Antigenics (NASDAQ:AGEN) on December 8th, 2014 at $3.30. In approximately 2 months, Antigenics has returned 57.27% as of today's recent price of $5.19.
AGEN: 5.03 (-0.01)

Agenus (AGEN) Is Today's Dead Cat Bounce Stock
at The Street - Mon Jan 26, 9:09AM CST
Trade-Ideas LLC identified Agenus (AGEN) as a "dead cat bounce" (down big yesterday but up big today) candidate
AGEN: 5.03 (-0.01)

Biotech Stock Mailbag: Arena Pharma, Agenus, EnteroMedics
at The Street - Fri Jan 23, 5:00AM CST
Biotech columnist Adam Feuerstein answers readers' questions about health care.
AGEN: 5.03 (-0.01), ETRM: 1.21 (+0.06), MRK: 58.81 (-0.07), INCY: 75.94 (+0.28), RCPT: 115.83 (-0.66), BMY: 60.04 (+0.56), ARNA: 4.55 (+0.02), NVS: 102.20 (-0.17)

Jim Cramer's 'Mad Money' Recap: Netflix Binge Buying Powered Today's Rally
at The Street - Wed Jan 21, 7:21PM CST
Does a single stock have the power to move the markets? Apparently Netflix does, Cramer says.
72.91 (-0.81), TSLA: 203.77 (+0.89), ODFL: 76.25 (+0.96), MMM: 165.94 (+0.03), BX: 37.40 (+0.49), GBX: 57.22 (-0.59), UNH: 109.44 (-0.40), KMB: 111.00 (+0.82), SDRL: 12.32 (-0.70), CVRR: 20.20 (+0.58), TWX: 83.87 (+0.56), LUV: 43.30 (-0.20), JNJ: 99.62 (+1.18), RICE: 19.13 (-0.22), IBM: 160.40 (+1.88), S: 5.23 (+0.08), HZNP: 16.84 (-0.41), CRZO: 52.60 (+1.17), AAPL: 127.08 (+0.62), UNP: 122.60 (-1.23), CY: 14.76 (+0.01), AMZN: 381.83 (+4.66), GPRO: 45.27 (-0.02), SWKS: 81.85 (-0.57), XEC: 112.01 (+1.04), DECK: 77.08 (+0.61), DIS: 104.17 (+0.59), CSLT: 9.19 (+0.13), MO: 54.76 (-0.78), BMY: 60.04 (+0.56), IDTI: 20.56 (-0.38), PCLN: 1,103.37 (+11.42), NFLX: 466.10 (+9.37), AGEN: 5.03 (-0.01), UA: 73.76 (-0.19), JCP: 8.05 (+0.14), MCD: 95.65 (+0.56), PG: 85.90 (-0.13), SNDK: 82.81 (+0.51), EPD: 34.44 (+0.19), FOLD: 8.36 (-0.11), BABA: 89.05 (+1.95)

Market At Its First Major Inflection Point Of 2015 - Final Chapter
Bret Jensen - at Seeking Alpha - Wed Jan 21, 5:41AM CST

AGEN: 5.03 (-0.01), SPY: 209.78 (+0.86), QQQ: 106.91 (+0.91), DIA: 180.34 (+0.50), IWM: 121.53 (+0.72), AAPL: 127.08 (+0.62)

64.1% Return Seen to Date on SmarTrend Antigenics Call (AGEN)
Comtex SmarTrend(R) - Fri Jan 16, 9:35AM CST
SmarTrend identified an Uptrend for Antigenics (NASDAQ:AGEN) on December 8th, 2014 at $3.30. In approximately 1 month, Antigenics has returned 64.09% as of today's recent price of $5.42.
AGEN: 5.03 (-0.01)

Agenus (AGEN) Shares March Higher, Can It Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jan 16, 7:40AM CST
Agenus (AGEN) Shares March Higher, Can It Continue?
AGEN: 5.03 (-0.01)

InsiderInsights.com Daily Round Up For 1/13/15: TWTR, WIW, STZ, ALL
InsiderInsights - at Seeking Alpha - Thu Jan 15, 8:54AM CST

STRM: 4.07 (+0.04), STZ: 113.03 (-0.48), CRDS: 2.32 (+0.05), PETX: 16.52 (-0.10), NNVC: 2.97 (-0.05), RM: 15.88 (+0.96), ALL: 71.46 (-0.11), TNET: 36.49 (+0.76), SFST: 17.20 (-0.42), AGEN: 5.03 (-0.01), GES: 19.01 (+0.49), WIW: 11.29 (unch), LRCX: 82.21 (+1.10), COST: 147.10 (-0.66), EBF: 13.90 (+0.02), TWTR: 48.50 (+0.55), JGW: 10.70 (-0.16), WIA: 11.49 (-0.03)

AstraZeneca Inks Immuno-Oncology Agreement with Omnis - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jan 14, 3:10PM CST
AstraZeneca (AZN) announced a deal with a privately held biotechnology company, Omnis Pharmaceuticals.
AGEN: 5.03 (-0.01), INCY: 75.94 (+0.28), AZN: 69.96 (+0.20)

Biotech Stock Roundup: Shire to Acquire NPSP, Celgene & Pharmacyclics Give Strong Outlook - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Jan 14, 1:39PM CST
Preliminary fourth quarter results and expectations for 2015 were key highlights in the biotech sector.
AGEN: 5.03 (-0.01), PCYC: 163.28 (+0.23), INCY: 75.94 (+0.28), NPSP: 45.88 (+0.03), AMGN: 153.48 (+0.30), REGN: 402.40 (+0.66), CELG: 115.88 (+0.16)

Earnings Forecast Research for Apple, Bank of America, Freeport-McMoRan, Agenus, Alibaba, and Sirius XM
PR Newswire - Wed Jan 14, 7:45AM CST
EarningForecast.com has issued earnings forecast research with special focus on the financial performances of the following stocks: Gilead Sciences (NASDAQ:GILD), Apple (NASDAQ:AAPL), Freeport-McMoRan (NYSE:FCX), Agenus (NASDAQ:AGEN), Alibaba (NYSE:BABA), and Sirius XM (NASDAQ:SIRI).
AGEN: 5.03 (-0.01), GILD: 101.90 (+1.10), FCX: 20.29 (+0.82), AAPL: 127.08 (+0.62), SIRI: 3.83 (-0.07), BABA: 89.05 (+1.95)

Nasdaq stocks posting largest volume increases
AP - Tue Jan 13, 5:15PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
ELOS: 10.16 (+0.07), INTG: 19.80 (+0.51), AGEN: 5.03 (-0.01), TRNS: 9.54 (+0.02), TFSC: 9.43 (+0.02), NLST: 1.86 (unch), MWIV: 189.72 (-0.17), NPSP: 45.88 (+0.03), LLEX: 1.17 (-0.09), NVC.TO: 11.27 (-0.23), NVCN: 9.08 (-0.17), TSRI: 4.24 (-0.01), HLSS: 16.15 (-0.14)

Most active Nasdaq-traded stocks
AP - Tue Jan 13, 5:15PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:
AGEN: 5.03 (-0.01), MU: 31.85 (-0.09), GILD: 101.90 (+1.10), FB: 75.74 (-0.49), NPSP: 45.88 (+0.03), MSFT: 43.87 (+0.78), INTC: 34.36 (+0.23), ARNA: 4.55 (+0.02), AAPL: 127.08 (+0.62), CSCO: 29.43 (-0.03), SNDK: 82.81 (+0.51)

Nasdaq stocks posting largest percentage increases
AP - Tue Jan 13, 5:15PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
XENT: 23.06 (+0.46), CLUB: 6.94 (+0.10), AGEN: 5.03 (-0.01), IMDZ: 25.34 (+1.20), PCYC: 163.28 (+0.23), ADHD: 6.92 (+0.73), TKMR: 21.45 (-0.22), FBSS: 17.59 (-0.11), TKM.TO: 26.51 (-0.73)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Celebree Gains Franchise Momentum: A New Frontier

The Climb: Celebree Schools on the Rise Here's a nugget in the franchise world that's causing a stir: Celebree School is making moves up the Franchise Times Top 400. When we're talking about a hop, skip, and jump through 84 spots since 2023, you can't help but notice. It's the third year in a row they're climbing this ladder, and it's making ripples. Franchise Expansion...

Fluence Energy Faces Major Lawsuit Amid $3B Loss

Securities Class Action: A Storm Brewing Just when you think you've got a grip on the market, a sharp right hook can come out of nowhere. Fluence Energy (NASDAQ:FLNC) is dealing with one of those punches now, getting dragged into the courtroom over claims they fudged financial lines. They hail innovation in energy storage, but shareholders are left shaking in their boots...

Think Tank Pushes for Bold Parkinson's Prevention Plan

A New Era for Parkinson's Disease Prevention The Parkinson's Foundation has rolled out its battle plan to take on Parkinson's disease from the ground up, shifting gears from managing symptoms to stopping the illness before it starts. It's about damn time, too. With the disease being the fastest-growing neurodegenerative disorder and impacting 10 million people worldwide,...

Omneky Outshines Competitors in AI Ad Scoring

Brewing a better ad with AI isn't just about the model you plug in—it's about the wizardry wrapping around it. Omneky's latest caper in the AI advertising game has snagged the spotlight, pulling a hearty 8.8 taste score on a recent TasteBench comparison. That's not a minor tweak, folks, but a whopping 1.2-point lead over the shadow-chasing curves of the next...

Montesodi 2023: A Fresh Chapter in Chianti Excellence

A Glass Filled with History and Nature's Whimsy When you pour a glass of Montesodi 2023, you’re not just tasting wine but a story—a saga that blends Tuscany’s rich vineyard history with last year's unpredictable weather. Marchesi Frescobaldi, a name that’s seen it all over its thousand years, has once again shown us how resilience and tradition can marry with...

Quark Baby's Milk Warmer Debut at Vancouver & Dubai

An Unconventional Pitch for Baby Gear Quark Baby is strutting its stuff not just in Vancouver but all the way in Dubai. Yeah, we're talking about a milk warmer hitting two major expos. What's the deal with an award-winning brand from Vancouver making so much noise? From October 17-18, they're home-court at The Baby Show Vancouver, and by October 22-24, they're in Dubai at...

Montessori and Tech: A New Era of Integration

Reimagining Montessori with Technology Let's take a stroll down the road less traveled—the intersection of Montessori education and tech. For over a century, Montessori schools have valued individual child development, autonomy, and a purpose-driven environment. But let's face it, their technology hasn't always had the same handcrafted finesse. That's where illumine...

Veterans Transitioning to Real Estate with Scholarships

Tapping Military Skills for Civilian Gain Finding a new career after military service is a mountain of a task, but veterans now have a golden ticket into the real estate appraisal world. The Appraisal Institute's Next Mission Scholarship is throwing veterans a $1,000 life preserver to dive into a field where their military-honed skills already shine. The Power of a...

Simple Home Upgrades That Boost Value Fast

Transform Your Home's Curb Appeal Without Breaking The Bank Every homeowner knows that feeling when you look at your house one day and think, "This could use a little something." Say you're strolling through a neighborhood in Fulton, N.Y., and notice a gem. It's not a brand new build, but it gleams with character. You bet it's had a few smart touches that could apply...

New American Funding Expands in Carolinas with Mullinix Move

The Gathering of Mortgage Titans You don't just waltz into the mortgage world with a $2 billion track record and expect folks not to notice. Will Mullinix, a name that's become synonymous in the Carolinas with mortgage mastery, has decided to bring his influential Mullinix Mortgage Group under the banner of New American Funding. Talk about a power play. This bold strategy...